Overview
Individuals with metabolic syndrome (MetS), particularly those with type 2 diabetes (T2D), and/or metabolic dysfunction-associated steatohepatitis or MASH face an elevated risk of major cardiovascular events (MACE). We showed decrease plams level of PPi in patients with liver cirrhosis. We hypothezised that liver transplant should block AC and restore PPi plasma level.
Eligibility
Inclusion Criteria:
- everyone requiring liver transplantation for the treatment of a chronic liver disease
Exclusion Criteria:
- MELD score \>25, viral replication